183 related articles for article (PubMed ID: 36533953)
1. Molecular Engineering of a Mammarenavirus with Unbreachable Attenuation.
Sakabe S; Cubitt B; Martinez-Sobrido L; de la Torre JC
J Virol; 2023 Jan; 97(1):e0138522. PubMed ID: 36533953
[TBL] [Abstract][Full Text] [Related]
2. Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.
Cheng BY; Ortiz-Riaño E; de la Torre JC; Martínez-Sobrido L
J Virol; 2015 Jul; 89(14):7373-84. PubMed ID: 25972555
[TBL] [Abstract][Full Text] [Related]
3. Development of live-attenuated arenavirus vaccines based on codon deoptimization.
Cheng BY; Ortiz-Riaño E; Nogales A; de la Torre JC; Martínez-Sobrido L
J Virol; 2015 Apr; 89(7):3523-33. PubMed ID: 25589652
[TBL] [Abstract][Full Text] [Related]
4. General Molecular Strategy for Development of Arenavirus Live-Attenuated Vaccines.
Iwasaki M; Ngo N; Cubitt B; Teijaro JR; de la Torre JC
J Virol; 2015 Dec; 89(23):12166-77. PubMed ID: 26401045
[TBL] [Abstract][Full Text] [Related]
5. The High Degree of Sequence Plasticity of the Arenavirus Noncoding Intergenic Region (IGR) Enables the Use of a Nonviral Universal Synthetic IGR To Attenuate Arenaviruses.
Iwasaki M; Cubitt B; Sullivan BM; de la Torre JC
J Virol; 2016 Jan; 90(6):3187-97. PubMed ID: 26739049
[TBL] [Abstract][Full Text] [Related]
6. A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region.
Cai Y; Iwasaki M; Motooka D; Liu DX; Yu S; Cooper K; Hart R; Adams R; Burdette T; Postnikova EN; Kurtz J; St Claire M; Ye C; Kuhn JH; Martínez-Sobrido L; de la Torre JC
mBio; 2020 Mar; 11(2):. PubMed ID: 32209677
[TBL] [Abstract][Full Text] [Related]
7. An mRNA-LNP-based Lassa virus vaccine induces protective immunity in mice.
Hashizume M; Takashima A; Iwasaki M
J Virol; 2024 Jun; 98(6):e0057824. PubMed ID: 38767352
[TBL] [Abstract][Full Text] [Related]
8. Development of Reverse Genetics for the Prototype New World Mammarenavirus Tacaribe Virus.
Ye C; de la Torre JC; Martínez-Sobrido L
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669332
[TBL] [Abstract][Full Text] [Related]
9. A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene.
Cai Y; Ye C; Cheng B; Nogales A; Iwasaki M; Yu S; Cooper K; Liu DX; Hart R; Adams R; Brady T; Postnikova EN; Kurtz J; St Claire M; Kuhn JH; de la Torre JC; Martínez-Sobrido L
mBio; 2020 Feb; 11(1):. PubMed ID: 32098811
[TBL] [Abstract][Full Text] [Related]
10. Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein.
Cheng BYH; Nogales A; de la Torre JC; Martínez-Sobrido L
Virology; 2017 Jan; 501():35-46. PubMed ID: 27855284
[TBL] [Abstract][Full Text] [Related]
11. Interactome analysis of the lymphocytic choriomeningitis virus nucleoprotein in infected cells reveals ATPase Na+/K+ transporting subunit Alpha 1 and prohibitin as host-cell factors involved in the life cycle of mammarenaviruses.
Iwasaki M; Minder P; Caì Y; Kuhn JH; Yates JR; Torbett BE; de la Torre JC
PLoS Pathog; 2018 Feb; 14(2):e1006892. PubMed ID: 29462184
[TBL] [Abstract][Full Text] [Related]
12. Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest.
Emonet SF; Garidou L; McGavern DB; de la Torre JC
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3473-8. PubMed ID: 19208813
[TBL] [Abstract][Full Text] [Related]
13. A small stem-loop-forming region within the 3'-UTR of a nonpolyadenylated LCMV mRNA promotes translation.
Hashizume M; Takashima A; Iwasaki M
J Biol Chem; 2022 Feb; 298(2):101576. PubMed ID: 35026225
[TBL] [Abstract][Full Text] [Related]
14. Reverse genetics approaches for the development of mammarenavirus live-attenuated vaccines.
Ye C; de la Torre JC; Martinez-Sobrido L
Curr Opin Virol; 2020 Oct; 44():66-72. PubMed ID: 32721864
[TBL] [Abstract][Full Text] [Related]
15. A Highly Conserved Leucine in Mammarenavirus Matrix Z Protein Is Required for Z Interaction with the Virus L Polymerase and Z Stability in Cells Harboring an Active Viral Ribonucleoprotein.
Iwasaki M; de la Torre JC
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593035
[TBL] [Abstract][Full Text] [Related]
16. Dual role of the lymphocytic choriomeningitis virus intergenic region in transcription termination and virus propagation.
Pinschewer DD; Perez M; de la Torre JC
J Virol; 2005 Apr; 79(7):4519-26. PubMed ID: 15767453
[TBL] [Abstract][Full Text] [Related]
17. Chaperonin TRiC/CCT Participates in Mammarenavirus Multiplication in Human Cells via Interaction with the Viral Nucleoprotein.
Sakabe S; Witwit H; Khafaji R; Cubitt B; de la Torre JC
J Virol; 2023 Feb; 97(2):e0168822. PubMed ID: 36656012
[TBL] [Abstract][Full Text] [Related]
18. Innate and adaptive immune control of genetically engineered live-attenuated arenavirus vaccine prototypes.
Pinschewer DD; Flatz L; Steinborn R; Horvath E; Fernandez M; Lutz H; Suter M; Bergthaler A
Int Immunol; 2010 Sep; 22(9):749-56. PubMed ID: 20584765
[TBL] [Abstract][Full Text] [Related]
19. Self-association of lymphocytic choriomeningitis virus nucleoprotein is mediated by its N-terminal region and is not required for its anti-interferon function.
Ortiz-Riaño E; Cheng BY; de la Torre JC; Martínez-Sobrido L
J Virol; 2012 Mar; 86(6):3307-17. PubMed ID: 22258244
[TBL] [Abstract][Full Text] [Related]
20. Envelope exchange for the generation of live-attenuated arenavirus vaccines.
Bergthaler A; Gerber NU; Merkler D; Horvath E; de la Torre JC; Pinschewer DD
PLoS Pathog; 2006 Jun; 2(6):e51. PubMed ID: 16751848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
